Project: GAP-ON€-2

Acronym GAP-ON€-2 (Reference Number: JPIAMR_2020_N004)
Duration 01/02/2021 - 02/01/2022
Project Topic The impact of antimicrobial resistance (AMR) is an almost invisible enemy, which slowly, but steadily has impacted society as a whole. Multi-, and/or pan-drug resistant strains have emerged, and have been spreading readily, causing deaths, disabilities and economic losses. Like for viruses, emergence of successful clones could further aggravate the immense impact of AMR on the global economy, especially if there is an outbreak of multi- or pan-resistant infections. As AMR has been rising slowly, little data has been available about its impact, especially for low- and middle income countries, and especially with regards to economic costs. Understanding how AMR currently affects health care expenditure and economic productivity in health care and agriculture, and how it is likely to do so in times of greater transmission in the future, are key to being able to making informed decision-making with regards to public health interventions, including economically-sound decisions such as surrounding the relative cost-effectiveness of interventions. To address the complex issue of building the cost picture associated with AMR, we have a three-step roadmap. In the first step, a cost framework completed by the GAP-ON€ network, funded under the 2018 Network Call. Also, GAP-ON€ also identified and contacted a list of 102 key stakeholders. The second step is to gather a smaller group of critical experts from all the One Health areas to co-write a much larger proposal detailing relevant data sources, data gaps, applicable methodologies, and their interconnectedness. The third step will be the actual cost study that needs to be undertaken to gauge the real cost magnitude associated with AMR. Such a major undertaking will require careful planning, and sufficient resources to carry out and coordinate. We plan to hold one F2F meeting amongst key experts to develop these study structures, map out potential funding sources, and write a coherent project proposal worthy of funding.
Website visit project website
Network JPI AMR
Call 10th Joint Call of JPIAMR

Project partner

Number Name Role Country
1 IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano Foundation Coordinator Italy
2 University of Antwerp Observer Belgium
3 CARB-X, Boston University Observer United States
4 University College Dublin Observer Ireland
5 University of Copenhagen Observer Denmark
6 Hospital Universitario Virgen Macarena Observer Spain
7 Norwegian Institute of Public Health Observer Norway
8 University Hospital Heidelberg Observer Germany
9 American University of Beirut Medical Center Observer Lebanon
10 University of Verona Observer Italy
11 Uppsala University Observer Sweden
12 The Wellcome Trust Observer United Kingdom
13 University Hospitals Geneva Observer Switzerland
14 University if KwaZulu-Natal Observer South Africa
15 Boehringer Ingelheim Pharmaceuticals Inc Observer United States
16 IRCCS Ospedale Policlinico San Martino Observer Italy
17 Universidad Maimónides Observer Argentina
18 National Institute for Infectious Diseases “Lazzaro Spallanzani” Observer Italy
19 Center for Disease Dynamics, Economics & Policy Observer India